Log in
Enquire now
‌

US Patent 10538524 Pyrazolopyrimidine derivatives useful as inhibitors of Bruton's tyrosine kinase

Patent 10538524 was granted and assigned to Loxo Oncology on January, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Loxo Oncology
Loxo Oncology
Current Assignee
Loxo Oncology
Loxo Oncology
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10538524
Date of Patent
January 21, 2020
Patent Application Number
15977470
Date Filed
May 11, 2018
Patent Citations Received
‌
US Patent 10662187 Bruton's tyrosine kinase inhibitors
Patent Primary Examiner
‌
Susanna Moore
Patent abstract

This invention relates to compounds of formula (I). The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10538524 Pyrazolopyrimidine derivatives useful as inhibitors of Bruton's tyrosine kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.